Characteristics | All |
Number | 334 |
Mean Age, years (SD) | 35.2 (10.5) |
Female Sex | 304 (92%) |
Race/Ethnicity | All |
White | 256 (77%) |
Latinx | 47 (16%) |
Black-African American | 21 (7%) |
Asian | 13 (4%) |
Black-African |
12 (4%) |
Other | 10 (4%) |
Comorbidities | All |
Obesity | 208 (63%) |
Pulmonary disease | 101 (30%) |
Tobacco smoking | 58 (17%) |
Diabetes | 25 (7%) |
CV disease | 8 (2%) |
COVID-19 Medications | All |
No treatment | 216 (65%) |
Azithromycin | 46 (15%) |
Corticosteroids | 42 (13%) |
Oxygen supplementation | 25 (8%) |
Anti-viral | 13 (3%) |
Anti-malarial | 8 (2%) |
IL-6 inhibitor | 1 (1%) |
COVID-19 Complications | All |
No serious events | 180 (54%) |
HS flare | 110 (33%) |
Shortness of breath | 49 (16%) |
Sepsis | 4 (1%) |
Death | 0 (0%) |
COVID-19 Treatment Location | All |
In hospital treatment | 24 (8%) |
ED treatment | 45 (15%) |
Home | 279 (84%) |